Clinical trial Recruiting at 1 site Observational Ages 18 and up

Postoperative pneumonia after coronary artery bypass grafting

Official title: The Impact of Nosocomial Pneumonia on the Outcome and Prognosis of Stable Coronary Artery Disease After Coronary Artery Bypass Grafting

Run by Tomsk National Research Medical Center of the Russian Academy of Sciences · NCT07476274 · Data updated 2026-11-12

This project will see if adults who develop non-ventilator hospital-acquired pneumonia after coronary artery bypass grafting have worse cardiopulmonary outcomes in the year after surgery than those who do not.

More Coronary Artery Disease trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment80 (estimated)
SponsorTomsk National Research Medical Center of the Russian Academy of Sciences
Academic / other
Locations1 site (Tomsk, Tomsk Oblast)
StatusRecruiting
StartedOctober 1, 2024
Main results expectedJune 30, 2026
Study endsJune 30, 2027
Registry record updatedMarch 23, 2026
Trial IDNCT07476274 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older who undergo CABG at the center, are transferred from intensive care to the general ward, have one or more risk factors for nosocomial pneumonia, and provide informed consent.

Probably not a fit

Patients with recent acute coronary syndrome, combined valve surgery, preoperative respiratory failure requiring support, tracheostomy, recent malignancy, participation in another clinical trial within three months, or life expectancy under one year are excluded and unlikely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, single-center, observational cohort at Tomsk NRMC comparing patients who develop non-ventilator-associated nosocomial pneumonia after CABG with those who do not. Participants receive clinical, laboratory (CBC, metabolic panel, cardiac, inflammatory, infectious, and endothelial biomarkers), functional (ECG, echocardiography, ultrasound, spirometry, cardiopulmonary exercise testing), and radiologic (chest X-ray/CT) examinations. The study is unblinded and follows patients to identify factors linked to early and one-year cardiopulmonary prognosis. Data will be analyzed to define phenotype differences and risk factors that could inform prevention and management of postoperative respiratory and cardiovascular complications.

Why it matters

Potential benefit: If successful, the findings could help identify patients at higher risk for cardiopulmonary complications after CABG and guide targeted prevention and follow-up.

How similar studies have gone: Previous research links pneumonia to worse cardiovascular outcomes generally, but the specific long-term cardiopulmonary impact of nosocomial pneumonia after CABG is largely unstudied, so this approach is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18 years and older.
* Myocardial revascularization for CAD via CABG during the current hospitalization, in accordance with the indications defined by the ESC/EACTS Guidelines on Myocardial Revascularization \[DOI: 10.1093/eurheartj/ehy394\].
* Successful transfer from the intensive care unit to a general ward after surgery.
* One or more of the risk factor for nosocomial pneumonia \[doi: 10.15829/1560-4071-2024-6094\].
* Signed informed consent for participation in the study.

Pre-operative Exclusion Criteria:

* Acute coronary syndrome within the last 1 month.
* Combined surgical intervention for infective endocarditis.
* Combined valve surgery.
* Concomitant pulmonary disease requiring respiratory support prior to surgery.
* Presence of a tracheostomy.
* Participation in another clinical trial at the time of potential inclusion or within the preceding 3 months.
* Diagnosis of malignant neoplasms within the last 5 years.
* Life duration of less than 1 year.
* HIV infection.

Peri-operative Exclusion Criteria:

* Ventilator-Associated Pneumonia (VAP).
* Acute Myocardial Infarction after CABG and before inclusion.
* Acute Stroke after CABG and before inclusion.
* Pulmonary after CABG and before inclusion.
* Pulmonary Edema after CABG and before inclusion.
* Acute Respiratory Distress Syndrome (ARDS) after CABG and before inclusion.
* Pneumothorax requiring drainage after CABG and before inclusion.
* Delirium after CABG and before inclusion.
* Chronic Kidney Disease (CKD) Stage 4-5 / Acute Kidney Injury requiring renal replacement therapy or chronic dialysis.
* Any perioperative complication requiring the patient's return to the intensive care unit or prolonging the ICU stay beyond 48 hours.
* Any other active infectious process at a different site.
* Novel Coronavirus Infection (COVID-19).

Where it's running

  • Cardiology Research Institute of Tomsk NRMC
    Tomsk, Tomsk Oblast, Russia
    Recruiting

Study contacts

  • Principal investigator: Alla A. Boshchenko, MD, PhD — Cardiology Research Institute of Tomsk NRMC
  • Study coordinator: Roman S. Timoshenko, MD
  • Email: trs@cardio-tomsk.ru
  • Phone: +79539244630

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.